These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 43001)

  • 1. [Reduction of mortality in acute myocardial infarction in patients treated with alprenolol. Preliminary results].
    Andersen M; Bechsgaard P; Frederiksen J; Hansen DA; Jürgensen HJ; Nielsen PB; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL
    Ugeskr Laeger; 1979 Nov; 141(45):3083-6. PubMed ID: 43001
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic alprenolol treatment of patients with acute myocardial infarction after discharge from hospital.
    Vedin A; Wilhelmsson C; Werkö L
    Acta Med Scand Suppl; 1975; 575():3-56. PubMed ID: 808105
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-blockers after myocardial infarction.
    Med Lett Drugs Ther; 1979 Dec; 21(25):101. PubMed ID: 44732
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Study design, patient characteristics and conduct of the study.
    Jürgensen HJ; Andersen MP; Bechsgaard P; Frederiksen J; Hansen DA; Nielsen PB; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL
    Acta Med Scand Suppl; 1984; 680():8-17. PubMed ID: 6375283
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Background and aims of the study.
    Jürgensen HJ
    Acta Med Scand Suppl; 1984; 680():4-7. PubMed ID: 6375279
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reduction of sudden death after myocardial infarct with chronic alprenolol treatment].
    Tibblin G; Vedin A; Wilhelmsen L; Werkö L; Wilhelmsson C
    Lakartidningen; 1975 Jun; 72(25):2683-6. PubMed ID: 1095869
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preventive effects of beta-blockers on myocardial infarction and on cardiac accidents following a first infarct].
    Fanchamps A
    Nouv Presse Med; 1978 Sep; 7(31):2741-5. PubMed ID: 30954
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Causes of death and post-mortem findings with special reference to early deaths.
    Hansen DA; Jürgensen HJ; Pedersen-Bjergaard O
    Acta Med Scand Suppl; 1984; 680():50-8. PubMed ID: 6375281
    [No Abstract]   [Full Text] [Related]  

  • 9. Alprenolol in acute myocardial infarction: Double-blind trial.
    Briant RB; Norris RM
    N Z Med J; 1970 Mar; 71(454):135-8. PubMed ID: 4392703
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.
    Frishman WH
    Am Heart J; 1980 Apr; 99(4):528-36. PubMed ID: 6102436
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Salvage of ischaemic myocardium by alprenolol.
    Jürgensen HJ; Frederiksen J; Hansen DA; Pedersen-Bjergaard O
    Acta Med Scand Suppl; 1984; 680():27-33. PubMed ID: 6375277
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results.
    Andersen MP; Bechsgaard P; Frederiksen J; Hansen DA; Jürgensen HJ; Nielsen B; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL
    Lancet; 1979 Oct; 2(8148):865-8. PubMed ID: 90964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of alprenolol on the extent myocardial infarction assessed by serial determination of serum creatine kinase].
    Jürgensen HJ; Frederiksen J; Hansen DA; Pedersen-Bjergaard O
    Ugeskr Laeger; 1979 Nov; 141(45):3089-91. PubMed ID: 392856
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-adrenergic blocking agents in prevention of sudden death.
    Chamberlain DA
    Adv Cardiol; 1978; 25():196-205. PubMed ID: 30260
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
    Tomov I
    Vutr Boles; 1984; 23(3):16-25. PubMed ID: 6147044
    [No Abstract]   [Full Text] [Related]  

  • 16. QT time in patients treated with alprenolol or placebo after myocardial infarction.
    Nyberg G; Vedin A; Wilhelmsson C
    Br Heart J; 1979 Apr; 41(4):452-5. PubMed ID: 380606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experiences with acute beta blockade in acute myocardial infarction].
    Pedersen F; Bechsgaard P; Nielsen PB; Rasmussen SL
    Ugeskr Laeger; 1979 Nov; 141(45):3086-9. PubMed ID: 43002
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results.
    Wilhelmsson C; Vedin JA; Wilhelmsen L; Tibblin G; Werkö L
    Lancet; 1974 Nov; 2(7890):1157-60. PubMed ID: 4139587
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of beta blockers for the reduction of mortality after myocardial infarction.
    Hampton JR
    Eur Heart J; 1981 Aug; 2(4):259-68. PubMed ID: 6117465
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beta blockers or ACE inhibitors following myocardial infarction in patients with diabetes?].
    Gystad K; Carlsen SM
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2565-9. PubMed ID: 11070998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.